SanofiSNYNF
13F holders, Q4 2025 (December 31)2holders −2
0new positions
2sold out
$97.13avg. 13F price*
At the end of Q4 2025, 2 institutions reported holding Sanofi (SNYNF) in their 13F filings, down 2 from Q3 2025. 0 opened new positions and 2 sold out. The largest holders were Generali Investments CEE, investicni spolecnost, a.s. ($3.0M) and GAMMA Investing LLC ($30K).
- Company
- Sanofi
- CUSIP
- F5548N101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 2 | $9.1M |
All 13F filers, Q3 2025 → Q4 2025: 522 shares bought and 192,524 shares sold, net −192,002 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Generali Investments CEE, investicni spolecnost, a.s. | 0.21% | Add +1.7% | 30,995 | $3.0M |
| GAMMA Investing LLC | 0.00% | No change | 306 | $30K |
"% of holder's portfolio" is SNYNF's weight in each manager's 13F, not the share of Sanofi the manager owns.